Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
February 14 2018 - 3:17PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
SEC File Number 000-54906
Form 10-Q
For
Period Ending: December 31, 2017
PART I: REGISTRANT INFORMATION
Full
Name of Registrant:
Cantabio Pharmaceuticals
Inc.
Address
of Principal Executive Office:
2225 East Bayshore Road #223
Palo Alto, California
(650)320-1765
PART
II: RULES 12B-25(B) AND (C)
It is
anticipated that the subject Quarterly Report on Form 10-Q will be
filed within the next several days.
PART
III: NARRATIVE
The
Registrant has not completed its Quarterly Report on Form 10-Q for
the period ended December 31, 2017 due to administrative
delays.
PART IV: OTHER INFORMATION
(1)
Name and telephone number of person(s) to contact in regard to this
notification
Thomas Roger Sawyer: 650-320-1765
(2)
Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the
Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the Registrant was required to file
such report(s) been filed? If the answer is no, identify
report(s).
[X] YES
[ ] NO
(3) Is
it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ] YES
[X] NO
If so,
attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Cantabio
Pharmaceuticals Inc. has caused this notification to be signed on
its behalf by the undersigned thereunto duly
authorized.
|
Cantabio Pharmaceuticals Inc.
|
|
|
|
|
|
Dated:
February 14, 2018
|
By:
|
/s/
Thomas Roger Sawyer
|
|
|
|
Thomas
Roger Sawyer
|
|
|
|
Chief
Operating Officer
|
|
Cantabio Pharmaceuticals (CE) (USOTC:CTBO)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cantabio Pharmaceuticals (CE) (USOTC:CTBO)
Historical Stock Chart
From Aug 2023 to Aug 2024